Tevi Troy Net Worth

Tevi Troy biography

Dr. Tevi Troy serves as Independent Director of the Company. Dr. Troy has served as Vice President of Public Policy for Juul Labs. From 2014 to 2018, Dr. Troy was the founder and CEO of the American Health Policy Institute. Before that, Dr. Troy was Senior Fellow at Hudson Institute, where he remains an Adjunct Fellow. On August 3, 2007, Dr. Troy was unanimously confirmed by the U.S. Senate as the Deputy Secretary of the U.S. Department of Health and Human Services. As Deputy Secretary, Dr. Troy was the chief operating officer of the largest civilian department in the federal government, with a budget of $716 billion and over 67,000 employees. Dr. Troy has extensive White House experience, having served in several high-level positions over a five-year period, culminating in his service as Deputy Assistant and then Acting Assistant to the President for Domestic Policy. Dr. Troy has held high-level positions on Capitol Hill as well. From 1998 to 2000, Dr. Troy served as the Policy Director for Senator John Ashcroft. From 1996 to 1998, Dr. Troy was Senior Domestic Policy Adviser and later Domestic Policy Director for the House Policy Committee, chaired by Christopher Cox. In addition to his senior level government work and health care expertise, Dr. Troy is also a best-selling presidential historian and the author of five books. Dr. Troy’s many other affiliations include: contributing editor for Washingtonian magazine; member of the publication committee of National Affairs; member of the Board of Fellows of the Jewish Policy Center; a Senior Fellow at the Potomac Institute; and a member of the Bipartisan Commission on Biodefense. Dr. Troy has a B.S. in Industrial and Labor Relations from Cornell University and an M.A and Ph.D. in American Civilization from the University of Texas at Austin. Dr. Troy is qualified to serve as a director because of his extensive knowledge of the healthcare industry and his significant leadership experience.

What is the salary of Tevi Troy?

As the Independent Director of Avalon GloboCare Corp, the total compensation of Tevi Troy at Avalon GloboCare Corp is $178,412. There are 11 executives at Avalon GloboCare Corp getting paid more, with Lu Wenzhao having the highest compensation of $4,047,220.

How old is Tevi Troy?

Tevi Troy is 52, he's been the Independent Director of Avalon GloboCare Corp since 2018. There are 5 older and 4 younger executives at Avalon GloboCare Corp. The oldest executive at Avalon GloboCare Corp is Wilbert Tauzin, 76, who is the Director.

What's Tevi Troy's mailing address?

Tevi's mailing address filed with the SEC is C/O AVALON GLOBOCARE CORP.,, 4400 ROUTE 9, SUITE 3100, FREEHOLD,, NJ, 07728.

Insiders trading at Avalon GloboCare Corp

Over the last 8 years, insiders at Avalon GloboCare Corp have traded over $2,500,000 worth of Avalon GloboCare Corp stock and bought 898,876 units worth $1,418,962 . The most active insiders traders include Wenzhao Lu, Luisa Ingargiola és Steven Andrew Sanders. On average, Avalon GloboCare Corp executives and independent directors trade stock every 157 days with the average trade being worth of $446,629. The most recent stock trade was executed by Wenzhao Lu on 1 April 2020, trading 645,161 units of AVCO stock currently worth $1,000,000.

What does Avalon GloboCare Corp do?

Avalon GloboCare Corp. is a clinical-stage, vertically integrated, leading CellTech bio-developer dedicated to advancing and empowering innovative, transformative immune effector cell therapy, exosome technology, as well as COVID-19 related diagnostics and therapeutics. Avalon also provides strategic advisory and outsourcing services to facilitate and enhance its clients' growth and development, as well as competitiveness in healthcare and CellTech industry markets. Through its subsidiary structure with unique integration of verticals from innovative R&D to automated bioproduction and accelerated clinical development, Avalon is establishing a leading role in the fields of cellular immunotherapy (including CAR-T/NK), exosome technology (ACTEX™), and regenerative therapeutics.

Avalon GloboCare Corp executives and stock owners

Avalon GloboCare Corp executives and other stock owners filed with the SEC include:

• Lu Wenzhao,
  Chairman of the Board of Directors
• Luisa Ingargiola,
  Chief Financial Officer
• David Jin,
  President, Chief Executive Officer, Director
• Li Meng,
  Chief Operating Officer, Secretary, Director
• Lu Yancen,
  Independent Director
• Dr. David K. Jin M.D., Ph.D.,
  CEO, Pres & Director
• Luisa Ingargiola,
  Chief Financial Officer
• Meng Li,
  COO, Sec. & Director
• Wilbert Tauzin,
  Director
• William Stilley,
  Independent Director
• Steven Sanders,
  Independent Director
• Tevi Troy,
  Independent Director
• Li Yue,
  Independent Director
• Steven Philip Sukel,
  Director